We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Two Harbors Investments Corp (TWO) - free report >>
Jazz Pharmaceuticals PLC (JAZZ) - free report >>
National CineMedia, Inc. (NCMI) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 16th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Jazz Pharmaceuticals plc (JAZZ - Free Report) is a biopharmaceutical company that provides pharmaceutical products for various unmet medical needs. The Zacks Consensus Estimate for its current year earnings has been revised 2.9% downward over the last 30 days.
Marinus Pharmaceuticals, Inc. (MRNS - Free Report) is a clinical stage pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 2.6% downward over the last 30 days.
Two Harbors Investment Corp. (TWO - Free Report) operates as a real estate investment trust. The Zacks Consensus Estimate for its current year earnings has been revised 12.1% downward over the last 30 days.
National CineMedia, Inc. (NCMI - Free Report) operates as cinema advertising network. The Zacks Consensus Estimate for its current year earnings has been revised 2.7% downward over the last 30 days.
Cronos Group Inc. (CRON - Free Report) operates as a cannabinoid company. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 60 days.
View the entire Zacks Rank #5 List.